Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE-Hb: Epoetin Alfa + IV Iron for Preoperative Anemia
NCT03528564Phase 2Terminated
- Sponsor
- Unity Health Toronto
- Start
- Jul 2019
- Primary completion
- May 2021
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in iron deficiency anemia (IDA), anemia of chronic disease (ACD), sponsored by Unity Health Toronto. Started Jul 2019; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
iron deficiency anemia (IDA)anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT03528564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03528564.